…

I joined the ENDOMIC team in 2016 as a study engineer to work on the functional role of autoantibodies in fibrotic diseases, more especially in systemic sclerosis, to define new endotypes linked to the anti-nuclear autoantibodies identified in patients. In 2018, I started a PhD still in the same field of research but focusing on autoimmune paraneoplastic syndromes to understand how cancer and autoimmunity can be linked from a molecular point of view.

In these two large projects, I bring my expertise in cell biology, biochemistry of proteins, and their analysis by conventional and omics methods. Since my defense in March 2022, I obtained a post-doc position to complete and deepen the works initiated by the implementation of multi-omics data integration methods and more mechanistic experimentations on the effect of autoantibodies in vitro and in vivo.